10th Biennial Symposium of the International Eosinophil Society, Inc.

会议摘要 R13请求为第十届两年一度的嗜酸性粒细胞研讨会--“2017”--提供会议支持， 于2017年7月19日至23日在瑞典哥德堡Elite Park Avenue酒店举行，由 国际嗜酸性粒细胞协会(IES)(www.eosinophil-Social ety.org)。本次会议将邀请约30人参加。 演讲者和大约150名额外的参与者，他们提交摘要以供演示。一个尖端程序 基础、翻译和临床研究已由当地组委会协商准备 与IES的科学计划委员会合作。该计划将包括以下内容：(1)宿主中的嗜酸性粒细胞 寄生虫相互作用，(2)嗜酸性粒细胞在胃肠道健康和疾病中的作用，3)嗜酸性粒细胞在 代谢调节，(4)过敏和超敏反应中的嗜酸性粒细胞，(5)先天、获得性和 自身免疫，(5)嗜酸性粒细胞诊断和治疗生物标志物，6)嗜酸性粒细胞发育的调节， 招募和存活，7)嗜酸性粒细胞组学，8)嗜酸性粒细胞和微生物群，以及9)针对青少年的课程 研究嗜酸性粒细胞的方法和资源的调查人员。这次会议的目标是提供一个 高度互动的跨学科论坛，供初级和成熟的科学家进行科学交流 变态反应、免疫学、微生物学、血液学和癌症领域与嗜酸性粒细胞在 健康和疾病。一个主要目标是将具有嗜酸性粒细胞生物学专业知识的基础科学家聚集在一起， 和临床研究人员对嗜酸性粒细胞相关疾病感兴趣，以提高对疾病的了解 嗜酸性粒细胞功能的机制、意义和促进翻译研究。第二个目标是 培养年轻调查人员的发展和兴趣，以帮助支持他们的职业生涯，创造一个新的 一代“嗜酸性粒细胞”。为了实现这一点，会议有一个类似Keystone的结构，所有参与者都参加了 在同一地点，在相同的基础上分享食物和住宿，鼓励非正式的互动。 将通过科学和社会方案强调为以下目标创建全球社区 嗜酸性粒细胞科学家。这次会议将特别及时，因为来自当前新的临床试验的数据 直接或间接阻断嗜酸性粒细胞介导的炎症途径的生物疗法现在 提供有关嗜酸性粒细胞在人类健康和疾病中的作用的明确数据。研讨会，以及它的 强调跨学科研究，涵盖重要的全球疾病，包括哮喘、嗜酸性粒细胞增多症 食管炎、寄生虫病和高嗜酸性粒细胞综合征。研讨会由全体会议和 海报会议，全体会议将来自该领域领导者的最先进的演讲与削减相结合 关于最新的高影响力研究的边缘讲座，包括从提交的摘要中挑选的口头陈述。 两个海报会议具有很高的优先级，没有人反对，还包括高影响研究的“旅行”。我们有 两次获奖演讲，第七届埃利希奖，表彰对该领域做出重大整体贡献的科学家， 格莱希奖授予前两年发表的论文影响最大的科学家。

CONFERENCE ABSTRACT R13 conference support is requested for the 10th Biennial Eosinophil Symposium – “Eosinophils 2017”, to be held from 19-23 July 2017 at the Elite Park Avenue Hotel, Gothenburg, Sweden, under the auspices of the International Eosinophil Society, Inc. (IES) (www.eosinophil-society.org). The meeting will host ~30 invited speakers and ~150 additional participants who submit abstracts for presentation. A cutting edge program of basic, translational and clinical research has been prepared by the Local Organizing Committee in consultation with the Scientific Program Committee of IES. The program will include sessions on: (1) eosinophils in host- parasite interactions, (2) eosinophils in gastrointestinal tract health and disease, 3) roles of eosinophils in metabolic regulation, (4) eosinophils in allergy and hypersensitivity, (5) eosinophils in innate, adaptive and autoimmunity, (5) eosinophil diagnostic and therapeutic biomarkers, 6) regulation of eosinophil development, recruitment and survival, 7) eosinophilomics, 8) eosinophils and microbiomes, and 9) a session targeting junior investigators on methods and resources for studying eosinophils. The goal of this conference is to provide a highly interactive, interdisciplinary forum for scientific exchange amongst junior and established scientists in the fields of allergy, immunology, microbiology, hematology and cancer in relation to the roles of eosinophils in health and disease. A primary objective is to bring together basic scientists with expertise in eosinophil biology, and clinician investigators interested in eosinophil-associated diseases, to improve understanding of disease mechanisms, significance of eosinophil functions, and foster translational research. A second objective is to foster the development and interests of younger investigators to help support their careers, creating a new generation of “eosinophiles”. To accomplish this, the meeting has a Keystone-like-structure with all participants in a single venue, sharing meals and accommodations on the same footing, encouraging informal interactions. There will be an emphasis through both the scientific and social programs on creating a global community for eosinophil scientists. This meeting will be particularly timely because data from current clinical trials of new biological therapies, which directly or indirectly block eosinophil-mediated inflammatory pathways, are now providing definitive data on the roles of eosinophils in human health and disease. The symposium, with its strong emphasis on inter-disciplinary research, covers important global diseases including asthma, eosinophilic esophagitis, parasitic diseases and hypereosinophilic syndromes. The symposium consists of plenary and poster sessions, with plenary sessions combining state-of-the-art talks from leaders in the field with cutting edge lectures on recent high impact studies, and include oral presentations selected from submitted abstracts. Two poster sessions have high priority, are unopposed and include “tours” of high-impact studies. We have two prize lectures, the 7th Ehrlich award for the scientist who has made a major overall contribution to the field, and the Gleich award for the scientist with the highest impact paper published over the previous two years.